Impact of Neoadjuvant Chemoradiotherapy on Health Related Quality of Life In Long-Term Survivors of Esophageal or Junctional Cancer: Results from the Randomized Cross Trial
A new study is out on quality-of-life measures for survivors who received neoadjuvant therapy versus surgery, suggesting that neoadjuvant chemoradiotherapy can be... Read More
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
A phase III randomized controlled trial published in The Lancet evaluated the efficacy of the PD-1 inhibitor Nivolumab in patients with previously... Read More
Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP‑2 and MMP‑9 expression via the p38MAPK signaling pathway
Researchers find silibinin inhibits the migration and invasion of gastric cancer SGC7901 cells by downregulating MMP‑2 and MMP‑9 expression by the p38MAPK... Read More
Nut and peanut butter consumption and the risk of esophageal and gastric cancer subtypes.
A new study explores the link between nut consumption and lowering the risk of esophageal and gastric cancers, particularly for older adults.
Clinicopathological features and prognoses in younger and older patients with gastric cancer
A Dove Press study explores the differences in clinicopathological prognoses and features in younger and older patients with gastric cancer.
First Gastric Cancer Patient Dosed In Clinical Trial Collaboration Evaluating Halozyme’s PEGPH20 In Combination With Anti-PDL1 Immunotherapy
The first gastric cancer patient is receiving doses in the clinical trial collaboration evaluating Halozyme’s PEGPH20 with anti-PDL1 immunotherapy.
Overexpression of MPC1 inhibits the proliferation, migration, invasion, and stem cell-like properties of gastric cancer cells
A new study in Dove Press finds the overexpression of MPC1 inhibits the proliferation, migration, invasion, and stem cell-like properties of gastric cancer... Read More
Bone health in long-term gastric cancer survivors: A prospective study of high-dose vitamin D supplementation using an easy administration scheme.
Physicians evaluated whether high doses of vitamin D after gastric cancer can improve bone health.
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
A phase III trial in The Lancet found the addition of rilotumumab (an antibody that targets the hepatocyte growth factor) to chemotherapy... Read More
CMIP is oncogenic in human gastric cancer cells
Researchers find c‑Maf inducing protein (CMIP) could be a novel target in the clinical therapeutic management of gastric cancer.
